Development of an experimental model of pemphigus vulgaris in laboratory animals
- 作者: Kubanov A.A.1, Karamova A.E.1, Rog K.V.1, Abramova T.V.2, Smolyannikova V.A.3, Murashev A.N.4, Bondarenko D.A.4
-
隶属关系:
- State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
- Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federation
- I. M. Sechenov First Moscow State Medical University
- Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences
- 期: 卷 91, 编号 4 (2015)
- 页面: 76-82
- 栏目: ORIGINAL STUDIES
- URL: https://journals.rcsi.science/0042-4609/article/view/116700
- DOI: https://doi.org/10.25208/0042-4609-2015-91-4-76-82
- ID: 116700
如何引用文章
全文:
详细
Pemphigus vulgaris is a chronic autoimmune bullous disease characterized by the formation of blisters on the skin and/ or mucous tunics as a result of acantholysis. To search for new molecular and biological targets, study pathogenetic mechanisms of the disease development and develop new methods of treatment, it is urgent to create an experimental model of pemphigus in laboratory animals reproducing clinical, histological and immunological signs of pemphigus. Goal of the study. To develop an experimental model of pemphigus by injecting IgG produced from the blood serum taken from patients with pemphigus to neonatal mice of the BALB/c inbred line. Results. Accumulated IgG products taken from patients with pemphigus (main groups) and healthy volunteers (control group) were injected intraperitoneally to neonatal mice of the BALB/с in the doses of 10-30 mg per mouse. Clinical, histological and immunomorphological signs of pemphigus were revealed in the mice from the main group, which received intraperitoneal injections of IgG taken from patients with pemphigus in the dose of 30 mg per mouse. No signs of pemphigus were observed in the mice from the control group, which received injections of IgG taken from healthy people. This study confirms the role of pemphigus autoantibodies in the pathogenesis of pemphigus vulgaris and shows that passive transmission of antibodies to laboratory animals is possible.
作者简介
A. Kubanov
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
编辑信件的主要联系方式.
Email: noemail@neicon.ru
俄罗斯联邦
A. Karamova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: noemail@neicon.ru
俄罗斯联邦
K. Rog
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: noemail@neicon.ru
俄罗斯联邦
T. Abramova
Russian Medical Academy of Postgraduate Studies, Ministry of Health of the Russian Federation
Email: abtava@mail.ru
俄罗斯联邦
V. Smolyannikova
I. M. Sechenov First Moscow State Medical University
Email: noemail@neicon.ru
俄罗斯联邦
A. Murashev
Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences
Email: noemail@neicon.ru
俄罗斯联邦
D. Bondarenko
Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry Russian Academy of Sciences
Email: noemail@neicon.ru
俄罗斯联邦
参考
- Karacheva YU.V., Gajdash А.А., Prokhorenkov V.I. Study of relation of acantolysis and apoptosis in pathogenesis of pemphigus vulgaris. Vestn dermatol venerol 2014; 2: 31-37.
- Kubanov А.А., Znamenskaya L.F., Аbramova T.V., Svishhenko S.I. Revisited diagnostics if true (acantholytic) pemphigus. Vestn dermatol venerol 2014; 6: 121-130.
- Grando S.A. Pemphigus autoimmunity: hypotheses and realities. Autoimmunity 2012; 45 (1): 7-35.
- Matushevskaya E.V., Kubanova А.А., Samsonov V.A. i dr. Autoantibodies and autoantigenes in pemphigus and pemphigoid. Vestn dermatol veneroli 1995; 5: 28-33.
- Stanley J.R., Yaar M., Hawley-Nelson P. et al. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse ke-ratinocytes. J Clin Invest 1982; 70: 281-288.
- Delva E., Jennings J.M., Calkins C.C., Kottke M.D., Faundez V., Kowalczyk A.P. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and esmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J BiolChem 2008; 283: 18303-18313.
- Koga H., Tsuruta D., Ohyama B. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris. Expert Opin-Ther Targets 2013; 17 (3): 293-306.
- Matushevskaya E.V., Svirshhevskaya E.V., Dzutseva I.R., Togoeva L.T., Lapshina T.P. Changes of anti-Dsg3 autoantibodies levels in serum of pemphigus patients before and after treatment. Vestn dermatol venerol 2005; 6: 12-16.
- Cozzani E., Di Zenzo G., Riva S., Calabresi V., Sera F., Drosera M., Parodi A. Are clinical phenotype and autoantibody profile always concordant in pemphigus? A study in a cohort of pemphigus patients. Eur J Dermatol 2013 Jan-Feb; 23 (1): 40-48.
- Schiltz J.R., Michel B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 1976 Aug; 67 (2): 254-60.
- Farb R.M., Dykes R., Lazarus G.S. Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl AcadSci USA 1978 Jan; 75 (1): 459-463.
- van der Wier G., Pas H.H., Jonkman M.F. Experimental human cell and tissue models of pemphigus // Dermatol Res Pract. - 2010. - 143871.
- Anhalt G.J., Labib R.S., Voorhees J.J. et al. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. J. Med 1982. 306: 20: 1189-1196.
- Mascaró J.M. Jr., España A., Liu Z., Ding X., Swartz S.J., Fairley J.A., Diaz L.A. Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol. 1997 Oct; 85 (1): 90-96.
- Osterman L.A. Research techniques of proteins and nucleic acids. electrophoresis and centrifugation. EHlektroforez i ul'tratsentrifugirovanie. M.: Nauka 1981: 288
补充文件
